BioSante Pharmaceuticals, Inc. (BPAX)
$1.50
-0.01 (-0.67%)
| CAPS Rating |
|
|---|---|
| Open | $1.46 |
| Previous Close | $1.50 |
| Daily Range | $1.45 - $1.52 |
| 52-Week Range | $0.81 - $2.70 |
| Market Cap | $80.48M |
| P/E Ratio | 11.26 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 128,085 |
| Average Daily Volume | 556,000 |
BPAX
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
BPAX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
BPAX News and Commentary
- UPDATE 1-BioSante says panel recommends drug trial to continue – Reuters
- BioSante Back at Key Support Levels – Blog at The Motley Fool
- The Fear Trade: Investors Pile into Gold and Treasuries – Blog at The Motley Fool
- BioSante Pharma Announces Re-Acquisition of Elestrin – Blog at The Motley Fool
- BioSante Pharma Explores Its Alternatives For LibiGel – Blog at The Motley Fool
Related News and Articles
- This Big Winner Has Hit Its Prime – The Motley Fool
- Dream Stocks for Biotech Investors – The Motley Fool
- Still Enjoying Those Acquisitions, Pfizer? – The Motley Fool
- Novartis Didn't Know JAK, Until Now – The Motley Fool
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
RSS Headlines
Fool UK
